Inventor · disambiguated record
Richard A. Bond
Also filed as: BOND RICHARD · BOND RICHARD A
4 granted patents·7 pending applications·11 citations·filing 2001–2024
67Inventor score
Top patents by PatentIndex Score
11 records- 0173US7528175B2Method of treating airway diseases with beta-adrenergic inverse agonistsINVERSEON INC·Filed 2005·Granted May 5, 2009·6 cites·16 claims
- 0273US2024180854A1Use of beta-adrenergic inverse agonists for smoking cessationINVION INC·Filed 2024·Application pending·0 cites
- 0363US9539221B2Method of treating airway diseases with β-adrenergic inverse agonistsBOND RICHARD A·Filed 2004·Granted Jan 10, 2017·5 cites·18 claims
- 0459US2018280323A1Use of beta-adrenergic inverse agonists for smoking cessationINVION INC·Filed 2018·Application pending·0 cites
- 0557US9993444B2Use of beta-adrenergic inverse agonists for smoking cessationBOND RICHARD A·Filed 2012·Granted Jun 12, 2018·0 cites·18 claims
- 0651US2010286224A1Method of treating airway diseases with beta-adrenergic inverse agonistsBOND RICHARD A·Filed 2009·Application pending·0 cites
- 0748US2009214643A1Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseasesFRANKLIN AMIE E·Filed 2006·Application pending·0 cites
- 0845US2022127576A1Compositions and methods for stem cell therapyUNIV ARIZONA·Filed 2020·Application pending·0 cites
- 0945US2007276024A1Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse AgonistsINVERSEON INC·Filed 2004·Application pending·0 cites
- 1043US9730889B2Steroid-sparing effects of beta-adrenergic inverse agonists and uses thereofBOND RICHARD A·Filed 2012·Granted Aug 15, 2017·0 cites·13 claims
- 1138US2001053795A1Paradoxical pharmacologyFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard A. Bond files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →